Skip to main content
OpenTrials

Clinical trial condition

Squamous Intraepithelial Lesions

Explore clinical trials studying Squamous Intraepithelial Lesions. Study availability and eligibility vary by location and protocol.

64 public trials 12 recruiting studies
Refine in advanced search Browse all conditions

Squamous Intraepithelial Lesions trial results

Completed

Treatment in Preventing Anal Cancer in Patients With HIV and Anal High-Grade Lesions

NCT02135419

Conditions
Acquired Immunodeficiency Syndrome, Anal Cancer, Anus Diseases, +38 more
Locations
  • UCLA CARE Clinic Los Angeles, California, United States
  • UCLA School of Nursing Los Angeles, California, United States
  • DAP Health Palm Springs, California, United States
  • University of California at San Francisco Anal Dysplasia Clinic San Francisco, California, United States
View all 25 locations
View Trial Details
Completed

A Study to Evaluate Safety, Efficacy of Intralesional Injection of STP705 in Patients With isSCC

NCT04844983

Conditions
Morphological and Microscopic Findings, Pathological Conditions, Signs and Symptoms, Squamous Cell Carcinoma in Situ, +1 more
Locations
  • Investigate MD Scottsdale, Arizona, United States
  • Center for Clinical and Cosmetic Research Aventura, Florida, United States
  • Research Institute of the Southeast LLC West Palm Beach, Florida, United States
  • Dermatology, Laser and Vein Specialists of the Carolinas Charlotte, North Carolina, United States
View Trial Details
Completed

Human Papillomavirus Vaccine Therapy in Treating Men With HIV-1 Infection

NCT00513526

Conditions
Atypical Squamous Cells of the Cervix, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +14 more
Locations
  • UCLA Clinical AIDS Research and Education (CARE) Center Los Angeles, California, United States
  • UCSF Helen Diller Family Comprehensive Cancer Center San Francisco, California, United States
  • Denver Health Medical Center Denver, Colorado, United States
  • Boston University Cancer Research Center Boston, Massachusetts, United States
View Trial Details
Completed

Validation of a Health-Related Symptom Index for Persons Diagnosed With and Either Treated or Monitored for Anal High-Grade Squamous Intraepithelial Lesions (HSIL)

NCT02836522

Conditions
Anal High-Grade Squamous Intraepithelial Lesions, Morphological and Microscopic Findings, Pathological Conditions, Signs and Symptoms, +1 more
Locations
  • Northwestern University Evanston, Illinois, United States
  • Memorial Sloan - Kettering Cancer Center New York, United States
  • City College of New York New York, United States
  • New York Presbyterian Hospital-Weill Medical College of Cornell University New York, United States
View Trial Details
Completed

REVEAL 1 (Evaluation of VGX-3100 and Electroporation for the Treatment of Cervical HSIL)

NCT03185013

Conditions
Cervical Dysplasia, Cervical High Grade Squamous Intraepithelial Lesion, Female Urogenital Diseases, +13 more
Locations
  • Mesa Obstetricians and Gynecologist Mesa, Arizona, United States
  • Women's Health Research Scottsdale, Arizona, United States
  • Visions Clinical Research-Tucson Tucson, Arizona, United States
  • Women's Medical Research Group Clearwater, Florida, United States
View all 60 locations
View Trial Details
Completed

VGX-3100 Delivered Intramuscularly (IM) Followed by Electroporation (EP) for the Treatment of HPV-16 and/or HPV-18 Related Anal or Anal/Peri-Anal, High Grade Squamous Intraepithelial Lesion (HSIL) in Individuals Seronegative for Human Immunodeficiency Virus (HIV)-1/2

NCT03499795

Conditions
Anal Neoplasm, Anus Diseases, Anus Neoplasms, +14 more
Locations
  • Howard Brown Health (HBH)-Sheridan Chicago, Illinois, United States
  • Laser Surgery Care New York, United States
  • Clinique de Recherche en Sante Québec, Quebec, Canada
View Trial Details

Related conditions